High intensity statin stroke guidelines
Web8 de mai. de 2012 · The SPARCL study reliably showed that high-dose atorvastatin at 80 mg/day reduces the risk of recurrent stroke and other cardiovascular events in patients … Web14 de abr. de 2024 · In the IMPROVE-IT trial, researchers showed adding ezetimibe to moderate-intensity statins vs. moderate intensity statin alone in ASCVD patients …
High intensity statin stroke guidelines
Did you know?
Web11 de abr. de 2024 · Among those who were prescribed statins, less than half (46.8%) were on guideline-recommended therapy with a high-intensity statin (compared with low- or moderate-intensity). Women were less likely to be prescribed a high-intensity statin than men (41.4% vs 49.8%, p <0.001, OR: 0.71 with 95% CI 0.68-0.73; Figures 2 and 3 ). Web8 de mai. de 2012 · Two large prospective randomized studies, the Heart Protection Study (simvastatin at 40 mg/day) and Stroke Prevention by Aggressive Cholesterol Reduction …
Web28 de jun. de 2024 · Abstract Background: Trial evidence supports statin use after ischemic stroke and recent American, European and British guidelines recommend high-intensity statins for this indication. Limited data are available describing current statin use among these patients in unselected settings. Web21 de jul. de 2024 · In those with ischemic stroke or TIA who have evidence of atherosclerotic disease, LDL-C lowering to <70mg/dL is recommended with statin and, if needed, ezetimibe, though a specific dose or intensity of statin is not specified.
Web18 de mai. de 2024 · Overall, these data convincingly showed that high-risk patients ages 65 to 82 enrolled in clinical trials derive substantial benefit from statin therapy. Mallery et al 2 contend that many of the secondary prevention statin trials evaluated composite outcomes over many years of follow-up and therefore are not generalizable to the frail … Web17 de ago. de 2024 · The guidelines suggest using high intensity statins (or the highest level you can tolerate) to reduce your LDL-C levels by 50% or more. 3. Those at high risk might benefit from nonstatins...
Web14 de abr. de 2024 · In the IMPROVE-IT trial, researchers showed adding ezetimibe to moderate-intensity statins vs. moderate intensity statin alone in ASCVD patients resulted in lower LDL cholesterol levels and reduced ASCVD events, especially in those older than age 75 years. 1 However, most guidelines recommend high-intensity statin therapy …
Web28 de jun. de 2024 · Abstract Background: Trial evidence supports statin use after ischemic stroke and recent American, European and British guidelines recommend high … ion streamingWeb13 de abr. de 2024 · Receiving guideline-recommended cholesterol-lowering therapy was defined as: (i) taking statin therapy of any intensity, with or without ezetimibe or a PCSK9i, among those without very high-risk ASCVD, (ii) taking statin therapy of any intensity with or without ezetimibe or a PCSK9i among those with very high-risk ASCVD and LDL-C < … on the good ship lollipop filmWeb19 de jan. de 2024 · Currently, experts recommend high intensity statins for four groups of people: 1) Those who have athersclerotic cardiovascular disease ( ASCVD) and are … on the google driveWeb2. Statin therapy has shown clear benefits and is recommended in four major groups of patients (strong evidence): 1,2. Patient Group Recommended Intensity of Statin Treatment Clinical ASCVD* Age ≤ 75 years with no statin-related safety concerns † a High Age > 75 years or with statin-related safety concerns Moderate . LDL . ≥ 190 mg/dL ... on the goog memeWeb2. Statin therapy has shown clear benefits and is recommended in four major groups of patients (strong evidence): 1,2. Patient Group Recommended Intensity of Statin … on the go olivesWeb18 de nov. de 2024 · Conclusions. After an ischemic stroke or TIA with evidence of atherosclerosis, patients who had a target LDL cholesterol level of less than 70 mg per deciliter had a lower risk of subsequent ... ion streamsWeb3 de out. de 2024 · High-intensity statin without risk assessment: Type 2 diabetes mellitus + 40 to 75 years old: Moderate intensity statin, risk estimation to consider high-intensity statin. Risk-enhancers in diabetics include ≥10 years for T2DM and 20 years for type 1 DM, ≥30 mcg albumin/mg creatinine, eGFR <60 mL/min/1.73 m 2, retinopathy, neuropathy, … on the google play store